RESPONSE
Robert Zeiser, M.D.
University of Freiburg, Freiburg, Germany
Takanori Teshima, M.D., Ph.D.
Hokkaido University, Sapporo, Japan
Franco Locatelli, M.D., Ph.D.
Ospedale Pediatrico Bambino Gesù, Rome, Italy
Latest NEJM has a response from some medicos to a previous article on Ruxolitinib trial and its' efficacy. Point 5 below - interesting given the channels Meso has had to jump through.
https://www.nejm.org/doi/full/10.1056/NEJMc2113499Ruxolitinib for Chronic Graft-versus-Host Disease
RESPONSE
Robert Zeiser, M.D.
University of Freiburg, Freiburg, GermanyTakanori Teshima, M.D., Ph.D.
Hokkaido University, Sapporo, JapanFranco Locatelli, M.D., Ph.D.
Ospedale Pediatrico Bambino Gesù, Rome, Italy
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
(20min delay)
|
|||||
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B |
Open | High | Low | Value | Volume |
92.0¢ | 92.5¢ | 91.5¢ | $1.133M | 1.233M |
No. | Vol. | Price($) |
---|---|---|
13 | 151980 | 91.5¢ |
Price($) | Vol. | No. |
---|---|---|
92.0¢ | 29989 | 2 |
No. | Vol. | Price($) |
---|---|---|
13 | 151980 | 0.915 |
17 | 171695 | 0.910 |
10 | 114726 | 0.905 |
41 | 340538 | 0.900 |
5 | 98985 | 0.895 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 29989 | 2 |
0.925 | 87769 | 6 |
0.930 | 71346 | 6 |
0.935 | 64930 | 3 |
0.940 | 14060 | 3 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
MSB (ASX) Chart |